The Serum Institute of India vaccine Covovax will get approval as a booster dose against Covid-19 in the next 10 to 15 days Chief Executive Officer of Serum Institute of India, Adar Poonawalla said.
Meanwhile, the CEO of Serum Institute of India Poonawalla said against the Omicron variant of coronavirus the vaccines work very well.
Addressing the Bharati Vidyapeeth University event on Sunday Poonawalla said, “Central Government has a lot of stock of Covisheild and also Covovax vaccine will get approval as a booster in the next 10 to 15 days.”
Answering about the availability and lack of supply of the Covisheild vaccine Adar said, “The central government has a lot of stock of Covisheild they can give it to the state, as of now production of Covisheild is at a halt at SII, we can start it if needed but the Covovax vaccine will get approval as a booster in the next 10 to 15 days, it works well against the Omicron variant of coronavirus.”
Poonawalla said, “During Covid-19, everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge population and also helped 70 to 80 nations, This was all possible because of the leadership of our central government and state governments, healthcare workers, manufacturers, all of whom worked together with one common goal.”
However, on the occasion of Dr. Patangrao Kadam’s birth anniversary in Maharashtra Poonawalla was also conferred with an award by NCP chief Sharad Pawar and Deputy CM Devendra Fadnavis.
